Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 466.00M | $ 280.00M | $ 807.00M | $ 581.00M | $ 805.00M |
Total Assets | $ 6.86B | $ 6.67B | $ 7.51B | $ 7.74B | $ 8.35B |
Total Debt | $ 1.39B | $ 1.25B | $ 1.46B | $ 1.37B | $ 1.69B |
Net Debt | $ 928.00M | $ 969.00M | $ 657.00M | $ 792.00M | $ 887.00M |
Total Liabilities | $ 4.32B | $ 4.22B | $ 4.84B | $ 5.06B | $ 5.65B |
Stockholders Equity | $ 2.54B | $ 2.44B | $ 2.67B | $ 2.69B | $ 2.70B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |